Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Why Sarepta Therapeutics Stock Is Soaring Today
Tickers SRPT
Tags Benzinga why it's moving News
From Benzinga
FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
Tickers SRPT
Tags FDA Biotech Market News
From Benzinga
2 Supercharged Growth Stocks to Buy Right Now
Tickers AMLX SRPT
Tags SRPT Recent Press Releases Market News
From Motley Fool
FDA advisers narrowly back accelerated approval of Sarepta gene therapy
Tickers SRPT
Tags SRPT
From MarketWatch
Why Sarepta Therapeutics Stock Faded This Week
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
FDA Staff Raises Issues For Sarepta's Duchenne Gene Therapy Data, Analyst Says Issues Known, Expects Positive Vote
Tickers SRPT
Tags Large Cap Trading Ideas News
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ABBV CI HCA JNJ
Tags HCA REGN NVAX
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers AZN CLDX CNMD GILD
Tags MRVI GILD REGN
From Benzinga
Expert Ratings for Sarepta Therapeutics
Tickers SRPT
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript
Tickers SRPT
Tags SRPT Recent Press Releases Market News
From Motley Fool
Sarepta Therapeutics Earnings Preview
Tickers SRPT
Tags Market News BZI/EP Earnings
From Benzinga
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
Tickers SGEN SGMO SRPT
Tags General Penny Stocks Partner Content
From Benzinga
The Latest Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Drug manufacturer Catalent’s stock tumbles 25% after profit warning and CFO departure
Tickers CTLT JNJ MRNA SPX
Tags JNJ SRPT SPX
From MarketWatch
Sarepta stock hit by renewed uncertainty about gene therapy treatment for rare disease
Tickers SPX SRPT
Tags SPX SRPT
From MarketWatch
Analysts Says Stat News Article Adds Uncertainty To Sarepta's SRP-9001, But Offers Buying Opportunity Around The Weakness
Tickers SRPT
Tags Expert Ideas FDA Biotech
From Benzinga
FDA Staff Had Inclination Towards Rejecting Sarepta Duchenne Gene Therapy
Tickers SRPT
Tags Briefs SRPT FDA
From Benzinga
Why Is Merck (MRK) Stock Up Today?
Tickers BABA BBAI MRK SRPT
Tags NYSE:MRK,NYSE:BABA,NYSE:BBAI,NASDAQ:SRPT Today's Market BBAI
From InvestorPlace
Why Is BigBear.ai (BBAI) Stock Down 5% Today?
Tickers BBAI SRPT WBD
Tags Market News WBD SRPT
From InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Down 12% Today?
Tickers GCTK SPWH SRPT WBD
Tags GCTK WBD SPWH
From InvestorPlace
Why Sarepta Therapeutics Stock Is Tumbling Today
Tickers SRPT
Tags SRPT Benzinga Market News
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers BNTC CELZ GCTK LSDI
Tags VRAY SABS MEDS
From Benzinga
2 Top Growth Stocks That Could Soar This Spring
Tickers REGN SRPT
Tags Recent Press Releases SRPT REGN
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Tickers ABCB AESI ASND AVAV
Tags DRS CSX ETSY
From Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Tickers CRSP EDIT GILD GNOM
Tags GILD EDIT NTLA
From InvestorPlace
3 Up-and-Coming Growth Stocks to Buy Right Now
Tickers AXSM SRPT TVTX
Tags Market News AXSM SRPT
From Motley Fool
TD Cowen Maintains Outperform Rating for Sarepta Therapeutics: Here's What You Need To Know
Tickers SRPT
Tags Analyst Ratings Market News BZI/AAR/UPDATE
From Benzinga
The Latest Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags Benzinga SRPT BZI/AAR
From Benzinga
Accelerated Approval For Gene Therapies - US Health Regulator Looks To Improve Process
Tickers SRPT
Tags Health Care Benzinga News
From Benzinga
Sarepta Therapeutics' FDA Adcomm Puts Some Risk, With Potential Approval: Analyst
Tickers SRPT
Tags Benzinga Analyst Ratings General
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.